Covered recipient · General Payments record
SETH M KLEINBECK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,552.19
- Reported across 263 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $457.12 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $159.76 | 12 |
| Amgen Inc. | $73.46 | 4 |
| DEXCOM, INC. | $35.19 | 2 |
| PFIZER INC. | $34.84 | 2 |
| Teleflex LLC | $28.37 | 1 |
| Acerta Pharma LLC | $28.16 | 1 |
| Mylan Specialty L.P. | $27.54 | 1 |
| ITI, Inc. | $20.19 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.54 | 1 |
| Novo Nordisk AS | $16.93 | 1 |
| Merck Sharp & Dohme Corporation | $15.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084916 | CMS |
| ABBVIE INC. | $17.84 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084918 | CMS |
| ABBVIE INC. | $27.52 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084920 | CMS |
| ABBVIE INC. | $7.06 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084922 | CMS |
| ABBVIE INC. | $12.53 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084924 | CMS |
| ABBVIE INC. | $17.01 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084926 | CMS |
| ABBVIE INC. | $20.82 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084928 | CMS |
| ABBVIE INC. | $17.93 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084930 | CMS |
| ABBVIE INC. | $2.36 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084932 | CMS |
| ABBVIE INC. | $10.63 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084934 | CMS |
| ABBVIE INC. | $10.28 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084936 | CMS |
| ABBVIE INC. | $4.78 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104084938 | CMS |
| Amgen Inc. | $20.96 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599874 | CMS |
| Amgen Inc. | $17.18 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599876 | CMS |
| Amgen Inc. | $17.56 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599878 | CMS |
| Amgen Inc. | $17.76 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599880 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.16 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105644928 | CMS |
| Dexcom, Inc. | $18.21 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335379 | CMS |
| Dexcom, Inc. | $16.98 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335381 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.19 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143257907 | CMS |
| Merck Sharp & Dohme LLC | $15.14 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141954510 | CMS |
| Mylan Specialty L.P. | $27.54 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147314722 | CMS |
| Novo Nordisk Inc | $16.93 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096968677 | CMS |
| PFIZER INC. | $16.22 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131366246 | CMS |
| PFIZER INC. | $18.62 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131635932 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.54 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153542162 | CMS |
| Teleflex LLC | $28.37 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142077291 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.